One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Compare complete versions: U.S. labeling uses 2-hour infusions, while UCSF uses 3-hour extended infusions. Nebraska separately lists an HD/PD interval different from the label. Do not select a dose from one version and an interval from another.
The FDA label uses a 2-hour infusion. UCSF reports 3 hours and a separate institutional dialysis schedule. Select a complete source before using a dose.
What to reconcile: The FDA label uses a 2-hour infusion. UCSF reports 3 hours and a separate institutional dialysis schedule. Select a complete source before using a dose.
Open this note and its source referencesDialysis evidence: A regimen is reported in selected content
Give after hemodialysis on HD days. Reassess CrCl at least daily when it is changing. Pediatric eGFR bands have a separate table.
| CrCl (mL/min) | Total IV combination dose over 2 hours | Interval |
|---|---|---|
| 31-50 | 1.25 g | Every 8 hours |
| 16-30 | 0.94 g | Every 12 hours |
| 6-15 | 0.94 g | Every 24 hours |
| <=5 | 0.94 g | Every 48 hours |
Adult renal doses are total combination grams infused over 2 hours. CrCl 31-50: 1.25 g every 8 hours. At 16-30: 0.94 g every 12 hours. At 6-15: 0.94 g every 24 hours. At <=5: 0.94 g every 48 hours. Give after hemodialysis on HD days. Reassess CrCl at least daily when it is changing. Pediatric eGFR bands have a separate table.
RDM73-avycaz-official-1 · Source locator: Renal guidance: 2.3, adult Table 3
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ceftazidime-avibactam&s1=RDM73-avycaz-official&h1=c8c35703374f132ab002e9de57cad670d568a759144b919bb14edb768316aa5f